Potential therapeutic effect of curcumin loaded hyalurosomes against inflammatory and oxidative processes involved in the pathogenesis of rheumatoid arthritis: The use of fibroblast-like synovial cells cultured in synovial fluid.


Journal

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
ISSN: 1873-3441
Titre abrégé: Eur J Pharm Biopharm
Pays: Netherlands
ID NLM: 9109778

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 17 11 2018
revised: 12 01 2019
accepted: 14 01 2019
pubmed: 20 1 2019
medline: 31 5 2019
entrez: 20 1 2019
Statut: ppublish

Résumé

In the present work curcumin loaded hyalurosomes were proposed as innovative systems for the treatment of rheumatoid arthritis. Vesicles were prepared using a one-step and environmentally friendly method. Aiming at finding the most suitable formulation in terms of size, surface charge and stability on storage, an extensive pre-formulation study was performed using different type and amount of phospholipids. Curcumin loaded vesicles prepared with 180 mg/ml of Phospholipon 90G (P90G) and immobilized with sodium hyaluronate (2 mg/ml) were selected because of their small size (189 nm), homogeneous dispersion (PI 0.24), negative charge (-35 mV), suitable ability to incorporate high amount of curcumin (E% ∼88%) and great stability on storage. The in vitro study using fibroblast-like synovial cells cultured in synovial fluid, demonstrated the ability of these vesicles to downregulate the production of anti-apoptotic proteins IAP1 and IAP2 and stimulate the production of IL-10, while the production of IL-6 and IL-15 and reactive oxygen species was reduced, confirming their suitability in counteracting pathogenesis of rheumatoid arthritis.

Identifiants

pubmed: 30659893
pii: S0939-6411(18)31451-6
doi: 10.1016/j.ejpb.2019.01.012
pii:
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Antioxidants 0
Drug Carriers 0
Inflammation Mediators 0
Phospholipids 0
Hyaluronic Acid 9004-61-9
Curcumin IT942ZTH98

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-92

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Maria Letizia Manca (ML)

Department of Scienze della Vita e dell'Ambiente, CNBS, University of Cagliari, Cagliari, Italy. Electronic address: mlmanca@unica.it.

Donatella Lattuada (D)

Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.

Donatella Valenti (D)

Department of Scienze della Vita e dell'Ambiente, CNBS, University of Cagliari, Cagliari, Italy.

Ornella Marelli (O)

Department of Medical Biotechnologies and Translational Medicine, University of Milan, Milan, Italy.

Costantino Corradini (C)

Department of Biomedical, Surgical and Dental Sciences University of Milan, Milan, Italy.

Xavier Fernàndez-Busquets (X)

Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain; Nanoscience and Nanotechnology Institute (IN2UB), University of Barcelona, Martí i Franquès 1, ES-08028 Barcelona, Spain.

Marco Zaru (M)

Icnoderm Srl, Sardegna Ricerche Ed. 5, 09010 Pula, Cagliari, Italy.

Anna Maria Maccioni (AM)

Department of Scienze della Vita e dell'Ambiente, CNBS, University of Cagliari, Cagliari, Italy.

Anna Maria Fadda (AM)

Department of Scienze della Vita e dell'Ambiente, CNBS, University of Cagliari, Cagliari, Italy.

Maria Manconi (M)

Department of Scienze della Vita e dell'Ambiente, CNBS, University of Cagliari, Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH